Myo inositol effective in preventing gestational diabetes
Written By : Dr Priyanka Ahuja
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-04-30 05:15 GMT | Update On 2022-04-30 05:15 GMT
Advertisement
India is the Diabetes capital of the world with 10-14% of pregnant women with diabetes. A meta-analysis in European journal of Obstetrics and gynaecology aims to study the efficacy of myo-inositol supplementation for the prevention of gestational diabetes.
The study found that Myo-inositol supplementation can be recommended to prevent gestational diabetes with some caution exercised.
Several databases including PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systemically searched from inception to October 2021, and were included in the randomized controlled trials (RCTs) assessing the effect of myo-inositol supplementation on the incidence of gestational diabetes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.